U.S. federal trademark · Serial No. 77056471 · Reg. No. 3763590
Evaluation services, namely, providing medical research relating to novel cancer pharmaceuticals; development for others of novel cancer therapeutics
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.